98-33886. Manufacturer of Controlled Substances; Notice of Registration

[Federal Register Volume 63, Number 246 (Wednesday, December 23, 1998)]
[Notices]
[Pages 71155-71156]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-33886]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated September 2, 1998, and published in the Federal 
Register on September 10, 1998, (63 FR 48522), Dupont Pharmaceuticals, 
The Dupont Merck Pharmaceutical Co., 1000 Stewart Avenue, Garden City, 
New York 11530, made application by renewal to the Drug Enforcement 
Administration (DEA) to be registered as a bulk manufacturer of the 
basic classes of controlled substances listed below:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Oxycodone (9143)...........................  II
Hydrocodone (9193).........................  II
Oxymorphone (9652).........................  II
------------------------------------------------------------------------

    The firm plans to manufacture the listed controlled substances to 
make finished products.
    No comments or objections have been received. DEA has considered 
the factors in Title 21, United States Code, Section 823(a) and 
determined that the registration of Dupont Pharmaceuticals to 
manufacture the listed controlled substances is consistent with the 
public interest at this time. DEA has investigated Dupont 
Pharmaceuticals on a regular basis to ensure that the company's 
continued registration is consistent with the public interest. These 
investigations have included inspection and testing of the company's 
physical security systems, audits of the company's records, 
verification of the company's compliance with state and local laws, and 
a review of the company's background and history. Therefore, pursuant 
to 21 U.S.C. 823 and 28 CFR 0.100 and 0.104, the Deputy Assistant 
Administrator, Office of Diversion Control, hereby orders that the 
application submitted by the above firm for registration as a bulk 
manufacturer of the basic classes of controlled substances listed above 
is granted.


[[Page 71156]]


    Dated: December 14, 1998.
John H. King,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 98-33886 Filed 12-22-98; 8:45 am]
BILLING CODE 4410-09-M